- Home
- INFU vs BTMD Comparison
INFU vs BTMD Comparison
Compare INFU & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INFU
- BTMD
- Stock Information
- Founded
- INFU 2005
- BTMD 2012
- Country
- INFU United States
- BTMD United States
- Employees
- INFU N/A
- BTMD N/A
- Industry
- INFU Medical/Dental Instruments
- BTMD Medicinal Chemicals and Botanical Products
- Sector
- INFU Health Care
- BTMD Health Care
- Exchange
- INFU Nasdaq
- BTMD Nasdaq
- Market Cap
- INFU 104.4M
- BTMD 104.2M
- IPO Year
- INFU N/A
- BTMD N/A
- Fundamental
- Price
- INFU $5.39
- BTMD $4.00
- Analyst Decision
- INFU
- BTMD Strong Buy
- Analyst Count
- INFU 0
- BTMD 1
- Target Price
- INFU N/A
- BTMD $8.00
- AVG Volume (30 Days)
- INFU 123.2K
- BTMD 181.8K
- Earning Date
- INFU 05-08-2025
- BTMD 05-07-2025
- Dividend Yield
- INFU N/A
- BTMD N/A
- EPS Growth
- INFU 3654.89
- BTMD 123.33
- EPS
- INFU 0.15
- BTMD 0.60
- Revenue
- INFU $137,582,000.00
- BTMD $199,379,000.00
- Revenue This Year
- INFU $10.91
- BTMD $6.20
- Revenue Next Year
- INFU $8.18
- BTMD $9.24
- P/E Ratio
- INFU $36.63
- BTMD $6.23
- Revenue Growth
- INFU 7.98
- BTMD 6.44
- 52 Week Low
- INFU $4.61
- BTMD $3.04
- 52 Week High
- INFU $9.97
- BTMD $8.44
- Technical
- Relative Strength Index (RSI)
- INFU 57.20
- BTMD 61.89
- Support Level
- INFU $4.67
- BTMD $3.15
- Resistance Level
- INFU $5.61
- BTMD $3.52
- Average True Range (ATR)
- INFU 0.22
- BTMD 0.22
- MACD
- INFU 0.11
- BTMD 0.07
- Stochastic Oscillator
- INFU 76.84
- BTMD 85.37
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.